小儿肺炎支原体肺炎合并腹泻的临床检验价值分析

Analysis of clinical test value for pediatric mycoplasma pneumoniae pneumonia complicated with diarrhea

目的分析小儿肺炎支原体肺炎合并腹泻的临床检验价值。方法 90例小儿肺炎支原体肺炎患儿作为研究对象,根据年龄不同将患儿分为婴幼儿组、学龄前组及学龄组,每组30例。采集所有患儿标本送检,比较三组患儿检测结果。结果婴幼儿组合并腹泻23例,其中用药前9例(30.00%),用药后14例(46.67%);学龄前组合并腹泻15例,其中用药前7例(23.33%),用药后8例(26.67%);学龄组合并腹泻10例,其中用药前2例(6.67%),用药后8例(26.67%);婴幼儿组用药前后合并腹泻情况高于学龄前组和学龄组,差异有统计学意义(P<0.05);且婴幼儿组用药前细菌性肠炎和轮状病毒感染例数明显高于用药后,真菌性肠炎例数明显低于用药后,差异有统计学意义(P<0.05)。结论小儿肺炎支原体肺炎合并腹泻患儿主要与机体免疫力和抗生素的滥用有关,故在临床治疗中应合理使用抗生素,确定最优的治疗方案,减轻患儿的痛苦,提高治疗效果,改善患儿预后。

Objective To analyze clinical test value for pediatric mycoplasma pneumoniae pneumonia complicated with diarrhea. Methods A total of 90 pediatric mycoplasma pneumoniae pneumonia complicated with diarrhea patients were divided by their age into infants group, preschool age group and school age group, with 30 cases in each group. Samples of all patients were taken and tested to compare test outcomes in the three groups. Results The infants group had 23 cases with complicated diarrhea, including 9 cases before medication（30.00%） and 14 cases after medication（46.67%）. The preschool age group had 15 cases with complicated diarrhea, including 7 cases before medication（23.33%） and 8 cases after medication（26.67%）. The school age group had 10 cases with complicated diarrhea, including 2 cases before medication（6.67%） and 8 cases after medication（26.67%）. The infants group had higher diarrhea complication condition before and after medication than the preschool age group and the school age group. Their difference had statistical significance（P〈0.05）. The infants groups had obviously higher cases with bacillary enteritis and rotavirus infection, lower cases with fungal enteritis before medication than those after medication, and their difference had statistical significance（P〈0.05）. Conclusion Pediatric mycoplasma pneumoniae pneumonia complicated with diarrhea is mainly related with organism immunity and antibiotics abuse, thus rational application of antibiotics in clinical treatment and determination of the best therapy scheme can relieve pain in patients, enhance curative effect and improve prognosis.